Tiger Group and EquipNet today announced an Oct. 16 timed online auction featuring 400 lots of advanced, lightly used scientific equipment from closed facilities operated by Venatorx Pharmaceuticals.
Agilent Technologies reported its third-quarter earnings for 2025, meeting expectations with an EPS of $1.37, while revenue outpaced forecasts at $1.74 billion, surpassing the anticipated $1.67 ...
Life sciences tools company Agilent Technologies (NYSE:A) will be reporting results this Wednesday after market close. Here’s what to expect. Agilent beat analysts’ revenue expectations by 2.7% last ...
Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. The main bioactive compounds in coffee beans affecting beverage quality include ...
Hyderabad: US-based analytical and clinical laboratory technologies player Agilent Technologies Inc has opened its new biopharma experience centre in Hyderabad. The facility will offer advanced ...
Agilent Technologies, a global leader in life sciences, diagnostics, and applied chemical markets opened its new Biopharma Experience Center in Hyderabad, Telangana. The facility marks a significant ...
NYSE-listed global leader in Life Sciences, diagnostics and applied chemical markets Agilent Technologies has established a Biopharma Experience Centre in Hyderabad to support the drug development ...
CHENNAI: Agilent Technologies, a global leader in life sciences, diagnostics, and applied chemical markets, has inaugurated its new Biopharma Capability Center in Hyderabad. The facility represents a ...
HYDERABAD, July 29 (Reuters) - U.S.-based laboratory equipment maker Agilent Technologies (A.N), opens new tab plans to double its investments in India to expand in one of its fastest-growing markets, ...
https://www.thehindubusinessline.com/companies/agilent-technologies-sets-up-biopharma-experience-centre-in-hyderabad/article69868494.ece Copy Agilent Technologies has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results